TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06627673: MultiCenter IDE Study of the PEEK-OPTIMA™ Femoral Component vs a CoCr Alloy TKA Femoral Component of Similar Design

Sponsor: Maxx Orthopedics Inc · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 200 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$11,040,000

Rescue Site Savings

+$7,279,500

Unlock Full NCT06627673 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06627673 Rescue Dossier →